GIGABYTE
GIGABYTE is exhibiting cutting-edge technologies and solutions at COMPUTEX 2023, presenting the theme “Future of COMPUTING”. From May 30th to June 2nd, GIGABYTE is showcasing over 110 products that are driving future industry transformation, demonstrating the emerging trends of AI technology and sustainability, on the 1st floor, Taipei Nangang Exhibition Center, Hall 1.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230525005657/en/
(Photo: Business Wire)
Win Big with AI through GIGABYTE’s Pioneering GPU/HPC Servers
GIGABYTE and its subsidiary, Giga Computing, are introducing unparalleled AI/HPC server lineups, leading the era of exascale supercomputing. One of the stars is the industry’s first NVIDIA-certified HGX H100 8-GPU SXM5 server, G593-SD0. Equipped with the 4th Gen Intel Xeon Scalable Processors and GIGABYTE’s industry-leading thermal design, G593-SD0 can perform extremely intensive workloads from generative AI and deep learning model training within a density-optimized 5U server chassis, making it a top choice for data centers aimed for AI breakthroughs.
In addition, GIGABYTE is debuting AI computing servers supporting NVIDIA Grace CPU and Grace Hopper Superchips. The high-density servers are accelerated with NVLink-C2C technology under the ARM Neoverse V2 platform, setting a new standard for AI/HPC computing efficiency and bandwidth.
Embrace Sustainability with GIGABYTE’s World-Acclaimed Green Computing Solutions
GIGABYTE’s green computing solutions are elevating the standards of data center energy efficiency to the next level. It is the first time for GIGABYTE to showcase three models of immersion cooling tanks at COMPUTEX, to demonstrate how green computing can eliminate the need for power-hungry fans and air conditioning. The solutions enable customers to therefore meet their sustainability goals while dealing with the surging demand for computing-heavy innovations.
In addition to green computing solutions, GIGABYTE is also highlighting its long-standing efforts in achieving “sustainable productivity” at COMPUTEX for the first time. GIGABYTE has been developing innovative eco-friendly products, optimizing production lines, which have reduced energy consumption by 34% and emissions by 43% since 2009, and practicing circular economy through e-waste repair, recycling, and refurbishment. In 2021 and 2022, GIGABYTE was rated “Leadership-Level” by CDP Climate Assessment for its distinguished sustainability actions and accomplishments.
Advance Data Centers with Next-Generation Server Selections
Technology development and digital services rely heavily on advanced data centers. GIGABYTE is exhibiting a wide range of servers and motherboards suitable for cloud computing, data storage, and edge computing, as well as servers displayed in EIA and OCP (Open Compute Project) standardized racks. The latest GIGABYTE enterprise products support the latest chips from AMD, Ampere, Intel, and NVIDIA, which allow data centers to benefit from optimized performance, flexibility, scalability, and efficiency.
Enable Smart Industry with GIGABYTE’s Superior AI-Driven Deployment
The development of network communication has spurred the rise of the Internet of Things (IoT). At COMPUTEX, GIGABYTE is showcasing how IoT can utilize AI technology to modernize manufacturing, retail, autonomous vehicles, healthcare, and other sectors. The key technology on display includes industrial motherboards, embedded systems, microcomputers, AI image recognition systems, and the Internet of Vehicles, leveraging next-generation chip technology to unlock boundless opportunities through digital transformation.
Reshape the Game with Award-Winning AORUS and AERO Computers
GIGABYTE has always adhered to a design philosophy that delivers outstanding consumer experience. AORUS gaming and AERO creator series have won 15 Red Dot Design Awards in 2023 across motherboards, graphics cards, laptops, large 4K monitors, and gaming peripherals, demonstrating GIGABYTE’s dedicated innovation and aesthetic excellence. In addition to the award-winning AORUS and AERO products, GIGABYTE will also showcase various selections of motherboards, SSD drives, and DIY kits, impressing tech enthusiasts with abundant choices of excellence.
Visit GIGABYTE’s COMPUTEX event page.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230525005657/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NHOA Energy Achieves Great Place To Work Certification in Italy, the United States and Australia18.12.2025 10:53:00 CET | Press release
NHOA Energy, global provider of utility-scale energy storage systems, announces that it has been certified Great Place To Work® in Italy, the United States, and Australia. The certification is based entirely on direct feedback from NHOA Energy employees, gathered through an independent and structured listening process. Great Place To Work® Certification™ assesses the quality of the employee experience across key dimensions such as credibility, respect, fairness, pride, and camaraderie. The results achieved by NHOA Energy reflect a corporate culture built on trust, inclusion, and the consistent commitment to valuing people within a dynamic and international environment. Employees highlighted particularly high levels of appreciation for the ethical and transparent behavior of leaders, the welcoming and inclusive approach toward new hires, and fair treatment across diversity, equity, and inclusion dimensions. A strong majority also expressed pride in working at NHOA Energy and reported a
Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 10:00:00 CET | Press release
The deal further strengthens Regnology’s global position in Regulatory Reporting and significantly accelerates its expansion into new markets Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeki
Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 10:00:00 CET | Press release
Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press release
Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half of study participants treated with zasocitinib achieved clear or almost clear skin (PASI 90), and on average about 30 percent achieved completely clear skin (PASI 100) by week 16 Zasocitinib was generally well-tolerated with a safety profile consistent with previous clinical studies Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at wee
DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press release
Based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only medicine to significantly improve overall survival versus chemotherapy in this patient population If approved, DATROWAY could become the standard of care in this setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Produc
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom